
GC30784
RG3039 (PF-06687859)
Also known as 5-[[1-[(2,6-dichlorophenyl)methyl]piperidin-4-yl]methoxy]quinazoline-2,4-diamine
RG3039 (PF-06687859) (PF-06687859) is an orally bioavailable and brain-penetrant DcpS inhibitor with an IC50 of 0·069 nM
ChemicalCAS1005504-62-0MW432.35FormulaC21H23Cl2N5O
- CAS number
- 1005504-62-0
- Molecular weight
- 432.35
- Formula
- C21H23Cl2N5O
- Solubility
- DMSO : 6 mg/mL (13·88 mM);Water : < 0·1 mg/mL (insoluble)
- InChIKey
- MNLHFGXIUJNDAF-UHFFFAOYSA-N
- Catalogue number
- GC30784
- Brand
- GLPBIO
Computed properties PubChem CID 53258905 · XLogP 4.3 · TPSA 90.3 Ų · H-bond donors 2
- XLogP
- 4.3
- TPSA
- 90.3 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 29
SMILES C1CN(CCC1COC2=CC=CC3=C2C(=NC(=N3)N)N)CC4=C(C=CC=C4Cl)Cl
Computed descriptors from PubChem (CID 53258905), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il